Spain· ES:89580
ARTEOPTIC PF 2% COLIRIO EN SOLUCION DE LIBERACION PROLONGADA
A medicinal product containing carteolol, registered in Spain by Bausch + Lomb Ireland Limited.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- carteolol
- Manufacturer
- Bausch + Lomb Ireland Limited
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- June 3, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Carteolol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCarteolol 1% eye dropsWaymade Healthcare Plc
- Japanカルテオロール塩酸塩大塚製薬
- BelgiumArteoptic LA 1 %Bausch & Lomb Pharma
- ItalyCARTEABAK*collirio 5 ml 1%LABORATOIRES THEA
- FranceCARTEOL 1 %, collyre en solutionLABORATOIRE CHAUVIN
- PolandCarteol LP 2%Delfarma Sp. z o.o.
- CzechiaCARTEOL LPDr. Gerhard Mann, Chem.- pharm. Fabrik GmbH, Berlín
- SwitzerlandArteoptic LA
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Arteoptic La, Arteoptic La Sine Conservans
- Czechia · Carteol Lp, Carteol Neo
- France · Carteol, Carteol L.P.
- Croatia · Cartelomb
- Italy · Carteabak, Carteol
- Luxembourg · Arteoptic La, Arteoptic La Sine Conservans
- Netherlands · Arteoptic Zonder Conserveermiddel, Carteabak
- Poland · Carteol Lp, Carteol Lp Preservative Free
- Portugal · Physioglau, Physioglau Pf
- Slovenia · Cartelomb
- Slovakia · Carteol Lp, Carteol Neo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/94e312e2-6aba-4e0c-b808-516139b49671 GET /v1/drugs/94e312e2-6aba-4e0c-b808-516139b49671?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica. Tratamiento De Larga Duración",
"estado": "{\"aut\":1716467702000}",
"nregistro": "89580",
"substance": "carteolol"
}See everything about carteolol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.